HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitsuhide Naruse Selected Research

Adrenalectomy

11/2022Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study.
10/2022Association of achieved blood pressure after treatment for primary aldosteronism with long-term kidney function.
1/2022Feasibility of Imaging-Guided Adrenalectomy in Young Patients With Primary Aldosteronism.
1/2021Association of aldosterone and blood pressure with the risk for cardiovascular events after treatments in primary aldosteronism.
1/2021Age-stratified comparison of clinical outcomes between medical and surgical treatments in patients with unilateral primary aldosteronism.
1/2021Adrenal Venous Sampling-Guided Adrenalectomy Rates in Primary Aldosteronism: Results of an International Cohort (AVSTAT).
10/2020Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension.
6/2020Age, Gender, and Body Mass Index as Determinants of Surgical Outcome in Primary Aldosteronism.
1/2020Obesity predicts persistence of resistant hypertension after surgery in patients with primary aldosteronism.
11/2019Predictors of Clinical Success After Surgery for Primary Aldosteronism in the Japanese Nationwide Cohort.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitsuhide Naruse Research Topics

Disease

54Hyperaldosteronism (Conn Syndrome)
03/2024 - 06/2003
27Adenoma (Adenomas)
05/2023 - 06/2003
24Hypertension (High Blood Pressure)
03/2024 - 10/2002
15Neoplasms (Cancer)
12/2023 - 01/2005
15Paraganglioma (Paragangliomas)
12/2023 - 01/2009
10Pheochromocytoma
12/2021 - 01/2009
9Cushing Syndrome
01/2022 - 02/2004
8Hypokalemia
03/2024 - 01/2014
6Neoplasm Metastasis (Metastasis)
12/2023 - 02/2006
5Hyperplasia
01/2022 - 02/2004
4Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 08/2004
3Adrenocortical Adenoma (Disease, Conn's)
01/2022 - 01/2015
3Diabetes Mellitus
10/2019 - 01/2009
3Dyslipidemias (Dyslipidemia)
12/2018 - 08/2008
3Hashimoto Disease (Thyroiditis, Hashimoto)
01/2015 - 01/2010
3Thyrotoxicosis
01/2012 - 08/2007
3Pituitary Neoplasms (Pituitary Adenoma)
09/2011 - 01/2005
3Fibrosis (Cirrhosis)
09/2009 - 10/2002
3Stroke (Strokes)
11/2004 - 07/2002
2Chronic Renal Insufficiency
10/2022 - 11/2014
2Adrenal incidentaloma
01/2022 - 06/2007
2Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2020 - 07/2002
2Proteinuria
10/2019 - 09/2019
2Essential Hypertension
01/2019 - 01/2018
2Type 2 Diabetes Mellitus (MODY)
01/2019 - 01/2003
2Thyroid Neoplasms (Thyroid Cancer)
01/2012 - 12/2007
2Graves Disease (Basedow Disease)
01/2012 - 03/2007
2Pain (Aches)
11/2010 - 05/2007
2Hyperalgesia
11/2010 - 05/2007
2Pancreatitis
11/2010 - 05/2007
2Body Weight (Weight, Body)
02/2009 - 05/2004
2Confusion (Bewilderment)
06/2007 - 06/2004
1AIDS-Related Complex (ARC)
01/2022
1Metabolic Bone Diseases (Osteopenia)
01/2022
1Osteoporosis
01/2022
1Carcinoma (Carcinomatosis)
06/2020
1Neuroblastoma
06/2020
1Ganglion Cysts (Ganglion)
06/2020

Drug/Important Bio-Agent (IBA)

46AldosteroneIBA
03/2024 - 07/2002
14Adrenocorticotropic Hormone (ACTH)FDA Link
03/2024 - 02/2004
14Hydrocortisone (Cortisol)FDA LinkGeneric
09/2022 - 06/2004
10Mineralocorticoid Receptor AntagonistsIBA
03/2024 - 07/2002
10ReninIBA
01/2022 - 06/2003
7CatecholaminesIBA
12/2021 - 07/2012
6Succinate Dehydrogenase (Fumarate Reductase)IBA
12/2023 - 01/2009
5Antihypertensive Agents (Antihypertensives)IBA
11/2022 - 01/2019
5Spironolactone (Aldactone)FDA LinkGeneric
01/2021 - 07/2002
5PotassiumIBA
10/2019 - 12/2007
4EnzymesIBA
05/2023 - 01/2021
4Cytochrome P-450 CYP11B2 (CYP11B2)IBA
07/2019 - 04/2013
4Dexamethasone (Maxidex)FDA LinkGeneric
01/2019 - 06/2004
4Angiotensin Receptor AntagonistsIBA
01/2019 - 07/2002
4Messenger RNA (mRNA)IBA
09/2009 - 07/2002
3Eplerenone (Inspra)FDA LinkGeneric
01/2021 - 08/2004
3Cosyntropin (Cortrosyn)FDA LinkGeneric
03/2020 - 02/2017
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2019 - 01/2003
3Dacarbazine (DIC)FDA LinkGeneric
01/2017 - 07/2012
3Hormones (Hormone)IBA
01/2014 - 08/2004
3candesartanIBA
11/2004 - 07/2002
2Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
03/2024 - 08/2004
2AntibodiesIBA
12/2021 - 03/2014
2alpha-Methyltyrosine (Metirosine)FDA Link
12/2019 - 03/2018
2Telmisartan (Micardis)FDA Link
01/2019 - 02/2009
2SteroidsIBA
01/2018 - 08/2004
2Vincristine (Oncovin)FDA LinkGeneric
01/2017 - 04/2013
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2017 - 04/2013
2Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA
01/2017 - 04/2013
2SodiumIBA
06/2014 - 12/2007
2CalciumIBA
01/2014 - 12/2007
2Nonsense Codon (Nonsense Mutation)IBA
01/2013 - 08/2009
2Thyrotropin Receptors (Thyrotropin Receptor)IBA
01/2012 - 12/2007
2Methimazole (Thiamazole)FDA LinkGeneric
01/2012 - 03/2007
2Peptide Hydrolases (Proteases)FDA Link
11/2010 - 05/2007
2CeruletideIBA
11/2010 - 05/2007
2Thyroxine (Levothyroxine)FDA LinkGeneric
01/2010 - 08/2007
1Succinic Acid (Succinate)IBA
12/2023
1GoldIBA
10/2023
1human MIRN631 microRNAIBA
01/2022
1ferriteIBA
01/2022
1Monoclonal AntibodiesIBA
01/2022
1MicroRNAs (MicroRNA)IBA
01/2022
1Dopamine beta-HydroxylaseIBA
12/2021
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
12/2021
1Choline O-Acetyltransferase (Choline Acetyltransferase)IBA
12/2021
1Acetylcholine (Acetylcholine Chloride)FDA Link
12/2021
13-Iodobenzylguanidine (Iobenguane)IBA
10/2021
1CreatinineIBA
01/2021
1ParaffinIBA
06/2020
1AntigensIBA
06/2020
1BuffersIBA
06/2020
1Gonadal Steroid Hormones (Sex Hormones)IBA
06/2020
1DiureticsIBA
01/2019
1Angiotensin II Type 1 Receptor BlockersIBA
01/2019
1azilsartanIBA
01/2019

Therapy/Procedure

24Adrenalectomy
11/2022 - 01/2008
9Therapeutics
12/2023 - 07/2002
4Aftercare (After-Treatment)
10/2022 - 01/2019
3Drug Therapy (Chemotherapy)
01/2017 - 07/2012
2Combination Drug Therapy (Combination Chemotherapy)
01/2017 - 04/2013
1Cystectomy
03/2020